Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2731682171;82172;82173 chr2:178564186;178564185;178564184chr2:179428913;179428912;179428911
N2AB2567577248;77249;77250 chr2:178564186;178564185;178564184chr2:179428913;179428912;179428911
N2A2474874467;74468;74469 chr2:178564186;178564185;178564184chr2:179428913;179428912;179428911
N2B1825154976;54977;54978 chr2:178564186;178564185;178564184chr2:179428913;179428912;179428911
Novex-11837655351;55352;55353 chr2:178564186;178564185;178564184chr2:179428913;179428912;179428911
Novex-21844355552;55553;55554 chr2:178564186;178564185;178564184chr2:179428913;179428912;179428911
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Ig-140
  • Domain position: 39
  • Structural Position: 58
  • Q(SASA): 0.4083
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F rs1704772471 None 0.059 N 0.211 0.289 0.566810639971 gnomAD-3.1.2 6.57E-06 None None None None N None 0 6.56E-05 0 0 0 None 0 0 0 0 0
L/F rs1704772471 None 0.059 N 0.211 0.289 0.566810639971 gnomAD-4.0.0 6.57488E-06 None None None None N None 0 6.55566E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.3495 ambiguous 0.3662 ambiguous -2.099 Highly Destabilizing 0.919 D 0.346 neutral None None None None N
L/C 0.6067 likely_pathogenic 0.6584 pathogenic -1.465 Destabilizing 0.999 D 0.44 neutral None None None None N
L/D 0.887 likely_pathogenic 0.9253 pathogenic -1.354 Destabilizing 0.996 D 0.519 neutral None None None None N
L/E 0.6419 likely_pathogenic 0.7242 pathogenic -1.258 Destabilizing 0.996 D 0.509 neutral None None None None N
L/F 0.1639 likely_benign 0.1869 benign -1.335 Destabilizing 0.059 N 0.211 neutral N 0.493705997 None None N
L/G 0.7178 likely_pathogenic 0.7725 pathogenic -2.515 Highly Destabilizing 0.988 D 0.483 neutral None None None None N
L/H 0.5328 ambiguous 0.6256 pathogenic -1.575 Destabilizing 0.999 D 0.529 neutral D 0.534220148 None None N
L/I 0.0775 likely_benign 0.0726 benign -0.973 Destabilizing 0.046 N 0.137 neutral N 0.451830601 None None N
L/K 0.5625 ambiguous 0.6614 pathogenic -1.489 Destabilizing 0.996 D 0.466 neutral None None None None N
L/M 0.1081 likely_benign 0.1156 benign -0.9 Destabilizing 0.988 D 0.449 neutral None None None None N
L/N 0.6965 likely_pathogenic 0.7791 pathogenic -1.448 Destabilizing 0.996 D 0.521 neutral None None None None N
L/P 0.563 ambiguous 0.5866 pathogenic -1.321 Destabilizing 0.995 D 0.521 neutral D 0.533966658 None None N
L/Q 0.3966 ambiguous 0.4963 ambiguous -1.477 Destabilizing 0.996 D 0.484 neutral None None None None N
L/R 0.4631 ambiguous 0.5573 ambiguous -1.011 Destabilizing 0.995 D 0.478 neutral D 0.545322964 None None N
L/S 0.564 ambiguous 0.6402 pathogenic -2.18 Highly Destabilizing 0.988 D 0.406 neutral None None None None N
L/T 0.3086 likely_benign 0.3369 benign -1.935 Destabilizing 0.919 D 0.354 neutral None None None None N
L/V 0.1007 likely_benign 0.0948 benign -1.321 Destabilizing 0.103 N 0.177 neutral N 0.47368874 None None N
L/W 0.3215 likely_benign 0.3954 ambiguous -1.398 Destabilizing 0.999 D 0.532 neutral None None None None N
L/Y 0.4786 ambiguous 0.5513 ambiguous -1.203 Destabilizing 0.952 D 0.407 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.